TELA Bio (TELA) Change in Accured Expenses (2018 - 2026)

TELA Bio has reported Change in Accured Expenses for 9 years, with the latest figure at $1.3 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses fell 5.45% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $1.1 million, a 12.95% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, up 197.29% from the prior year.
• Change in Accured Expenses was $1.3 million for Q2 2026 at TELA Bio, up from -$1.5 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $2.8 million in Q4 2023, with the low at -$3.5 million in Q1 2024.
• Average Change in Accured Expenses over 5 years is $352611.1, with a median of $755000.0 recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses plunged 130.03% in 2024, then surged 178.74% in 2025.
• Over 5 years, Change in Accured Expenses stood at $1.6 million in 2022, then soared by 75.25% to $2.8 million in 2023, then slumped by 130.03% to -$842000.0 in 2024, then soared by 178.74% to $663000.0 in 2025, then soared by 98.79% to $1.3 million in 2026.
• The last three Change in Accured Expenses figures came in at $1.3 million (Q2 2026), -$1.5 million (Q1 2026), and $663000.0 (Q4 2025), per Business Quant data.